Global Hyperparathyroidism Market 2024-2028

The hyperparathyroidism market is forecasted to grow by USD 486.7 mn during 2023-2028, accelerating at a CAGR of 7.1% during the forecast period. The report on the hyperparathyroidism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in thyroid treatment awareness programs, growing focus on emerging economies, and increasing drug discovery.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.7%
CAGR	7.1%
Incremental Value	$486.7 mn

Technavio's hyperparathyroidism market is segmented as below:

By Disease Type

Secondary hyperparathyroidism
Primary hyperparathyroidism
Tertiary hyperparathyroidism

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing inorganic growth strategies among vendors as one of the prime reasons driving the hyperparathyroidism market growth during the next few years. Also, growing penetration of e-commerce for drug retail and rising clinical trials for hyperparathyroidism treatment will lead to sizable demand in the market.

The report on the hyperparathyroidism market covers the following areas:

Hyperparathyroidism Market sizing
Hyperparathyroidism Market forecast
Hyperparathyroidism Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyperparathyroidism market vendors that include AbbVie Inc., Accord Healthcare Ltd., AdvaCare Pharma, Alkem Laboratories Ltd., Amgen Inc., Ascendis Pharma AS, Aurobindo Pharma Ltd., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., EA Pharma Co. Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Lupin Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.. Also, the hyperparathyroidism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR80227

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Hyperparathyroidism Market 2018 - 2022
- Historic Market Size - Data Table on Global Hyperparathyroidism Market 2018 - 2022 ($ million)
5.2 Disease Type segment analysis 2018 - 2022
- Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
5.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 The Impact of AI on Global Hyperparathyroidism Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Disease Type

8.1 Market segments
- Chart on Disease Type - Market share 2023-2028 (%)
- Data Table on Disease Type - Market share 2023-2028 (%)
8.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
8.3 Secondary hyperparathyroidism - Market size and forecast 2023-2028
- Chart on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Data Table on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Chart on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
- Data Table on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.4 Primary hyperparathyroidism - Market size and forecast 2023-2028
- Chart on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Data Table on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Chart on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
- Data Table on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.5 Tertiary hyperparathyroidism - Market size and forecast 2023-2028
- Chart on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Data Table on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
- Chart on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
- Data Table on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacy - Market size and forecast 2023-2028
- Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
9.4 Retail pharmacy - Market size and forecast 2023-2028
- Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
9.5 Online pharmacy - Market size and forecast 2023-2028
- Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
11.12 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
11.13 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.14 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)
11.15 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.16 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
14.5 Alkem Laboratories Ltd.
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
- SWOT
14.6 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
14.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
14.8 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
14.9 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
14.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
14.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.12 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus
- SWOT
14.13 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
14.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
14.15 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
14.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
14.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
14.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations